Radioactive iodine therapy for low and intermediate risk thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial studies how well radioactive iodine treatment works for people with certain types of thyroid cancer that have a low or intermediate risk of coming back. It aims to see if this treatment is effective and safe for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of thyroid cancer called differentiated thyroid cancer (includes papillary and follicular types).
- You have had your entire thyroid gland removed (total thyroidectomy), with or without removal of nearby lymph nodes.
- You have already received radioactive iodine treatment after your surgery.
- You are 18 years or older.
- You do not have high-risk cancer (cancer that has spread to distant parts of the body), medullary thyroid cancer, or another type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
This study looks at how different doses of radioactive iodine affect people with thyroid cancer after they have had their thyroid removed. It may help doctors choose the best dose for future patients.
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This study looks at whether adding radiation therapy after surgery can help people with thyroid cancer that is at high risk of coming back. It includes different types of thyroid cancer, like differentiated and medullary types.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.